SUDOSCAN efficacy in early detection of diabetic neuropathy has been demonstrated in several studies.
Small fiber neuropathies have been assessed using SUDOSCAN in different diseases and therapeutic areas.
SUDOSCAN has demonstrated its clinical utility to detect chemotherapy induced polyneuropathy (CIPN).
SUDOSCAN has demonstrated its clinical utility in Nephrology.
A key clinical application of SUDOSCAN is longitudinal follow-up and patient management.
Objective screening of diabetes risk through non invasive assessment of Sudomotor function using Ezscan score
SUDOSCAN is a medical device that offers a stimulation of the sweat glands that assess small nerve fibers.
Learn about Impeto Medical’s mission, innovation, patents, and commitment to early detection through less invasive medical screening.
Discover Impeto Medical’s global presence, regulatory registrations, and international access to SUDOSCAN and EZSCAN technologies.
An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy.
Simple results obtained in 3 minutes.